Homepage > Company > Media > Pharma News > 2018 > Lupin intros generic Vibra-Tabs

Lupin intros generic Vibra-Tabs

Lupin has introduced its generic Vibra-Tabs (doxycycline hyclate). The company’s generic will be available in 100-mg dosage strength tablets.

Lupin’s generic of Pfizer’s Vibra-Tabs is indicated to treat infections caused by various microorganisms, and as an adjunctive treatment for severe acne.

The product had U.S. sales of roughly $144 million for the 12 months ended November 2017, according to IQVIA data.

January 19, 2018

https://www.drugstorenews.com/

Read also

FDA declines to grant EUA for antidepressant to treat Covid-19

The data was inadequate to conclude that the drug was effective in preventing disease progression, FDA noted.

Drug treatment for cataracts moves a step closer

A revolutionary new treatment for cataract has shown extremely positive results in laboratory tests, giving hope that the condition, that currently can only be cured with surgery, could soon be tre...

U.S. says use of Pfizer's COVID-19 antiviral up 315%

Use of Pfizer Inc’s (PFE.N) COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Department of Health and Human Services said on Tuesday, as health offici...

MHRA Approves Verzenios for Certain Types of Early Breast Cancer

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization to Eli Lilly’s Verzenios (abemaciclib) in combination with endocrine therapy for adjuvant...